Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ICS 205-930' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mhatre, MC; Garrett, KM; Holloway, FA
      5-HT3 receptor antagonist ICS 205-930 alters the discriminative effects ofethanol

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    2. Rodd-Henricks, ZA; McKinzie, DL; Edmundson, VE; Dagon, CL; Murphy, JM; McBride, WJ; Lumeng, L; Li, TK
      Effects of 5-HT3 receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats

      ALCOHOL
    3. McKinzie, DL; McBride, WJ; Murphy, JM; Lumeng, L; Li, TK
      Effects of MDL 72222, a serotonin(3) antagonist, on operant responding forethanol by alcohol-preferring P rats

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    4. Chesnoy-Marchais, D
      Mode of action of ICS 205,930, a novel type of potentiator of responses toglycine in rat spinal neurones

      BRITISH JOURNAL OF PHARMACOLOGY
    5. WILSON AW; NEILL JC; COSTALL B
      AN INVESTIGATION INTO THE EFFECTS OF 5-HT AGONISTS AND RECEPTOR ANTAGONISTS ON ETHANOL SELF-ADMINISTRATION IN THE RAT

      Alcohol
    6. MCKINZIE DL; EHA R; COX R; STEWART RB; DYR W; MURPHY JM; MCBRIDE WJ; LUMENG L; LI TK
      SEROTONIN(3) RECEPTOR ANTAGONISM OF ALCOHOL INTAKE - EFFECTS OF DRINKING CONDITIONS

      Alcohol
    7. NICOLAIDES C; GIANNAKAKIS T; SKARLOS D; ATHANASSIADIS A; FOUNTZILAS G; DAMIGOS D; PAVLIDIS N
      TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN

      Journal of experimental & clinical cancer research
    8. Darmani, NA
      Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis

      JOURNAL OF NEURAL TRANSMISSION
    9. SILVESTRE JS; PALACIOS JM; FERNANDEZ AG; ONEILL MF
      COMPARISON OF EFFECTS OF A RANGE OF 5-HT RECEPTOR MODULATORS ON CONSUMPTION AND PREFERENCE FOR A SWEETENED ETHANOL SOLUTION IN RATS

      JOURNAL OF PSYCHOPHARMACOLOGY
    10. DYR W; KOSTOWSKI W
      EFFECTS OF 5-HT3 RECEPTOR AGONISTS ON VOLUNTARY ETHANOL INTAKE IN RATS MAINTAINED ON A LIMITED ACCESS PROCEDURE

      Alcohol and alcoholism
    11. MICHEL K; SANN H; SCHAAF C; SCHEMANN M
      SUBPOPULATIONS OF GASTRIC MYENTERIC NEURONS ARE DIFFERENTIALLY ACTIVATED VIA DISTINCT SEROTONIN RECEPTORS - PROJECTION, NEUROCHEMICAL CODING, AND FUNCTIONAL IMPLICATIONS

      The Journal of neuroscience
    12. SCARPIGNATO C
      PHARMACOLOGICAL STIMULATION OF GASTROINTESTINAL MOTILITY - WHERE WE ARE AND WHERE ARE WE GOING

      Digestive diseases
    13. PITSIKAS N; BORSINI F
      DIFFERENT EFFECTS OF TROPISETRON AND ONDANSETRON IN LEARNING AND MEMORY PARADIGMS

      Pharmacology, biochemistry and behavior
    14. YAMANO M; KAMATO T; NAGAKURA Y; MIYATA K
      EFFECTS OF GASTROPROKINETIC AGENTS ON GASTROPARESIS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    15. GIORDANO J; SACKS SM
      SUB-ANESTHETIC DOSES OF BUPIVACAINE OR LIDOCAINE INCREASE PERIPHERAL ICS-205 930-INDUCED ANALGESIA AGAINST INFLAMMATORY PAIN IN RATS

      European journal of pharmacology
    16. MASWOOD N; CALDAROLAPASTUSZKA M; UPHOUSE L
      5-HT3 RECEPTORS IN THE VENTROMEDIAL NUCLEUS OF THE HYPOTHALAMUS AND FEMALE SEXUAL-BEHAVIOR

      Brain research
    17. SILVERSTONE PH; GREENSHAW AJ
      5-HT3 RECEPTOR ANTAGONISTS

      Expert opinion on therapeutic patents
    18. CAMPBELL AD; KOHL RR; MCBRIDE WJ
      SEROTONIN-3 RECEPTOR AND ETHANOL-STIMULATED SOMATODENDRITIC DOPAMINE RELEASE

      Alcohol
    19. LE AD; TOMKINS DM; SELLERS EM
      USE OF SEROTONIN (5-HT) AND OPIATE-BASED DRUGS IN THE PHARMACOTHERAPYOF ALCOHOL DEPENDENCE - AN OVERVIEW OF THE PRECLINICAL DATA

      Alcohol and alcoholism
    20. ALI Z; WU G; KOZLOV A; BARASI S
      THE ROLE OF 5HT(3) IN NOCICEPTIVE PROCESSING IN THE RAT SPINAL-CORD -RESULTS FROM BEHAVIORAL AND ELECTROPHYSIOLOGICAL STUDIES

      Neuroscience letters
    21. DUMAINE R; HARTMANN HA; LEISHMAN DJ; BROWN AM; GALVAN M
      ACTIONS OF DOLASETRON AND ITS MAJOR METABOLITE ON GUINEA-PIG PAPILLARY-MUSCLE FIBERS AND THE ALPHA-SUBUNIT OF HUMAN HEART SODIUM-CHANNELS EXPRESSED IN XENOPUS OOCYTES

      Drug development research
    22. FEINLE C; READ NW
      ONDANSETRON REDUCES NAUSEA INDUCED BY GASTRODUODENAL STIMULATION WITHOUT CHANGING GASTRIC-MOTILITY

      American journal of physiology: Gastrointestinal and liver physiology
    23. KULKARNI SK; ROYCHOUDHURY M
      5-HT3 RECEPTORS - A REVIEW OF THEIR PHARMACOLOGICAL AND THERAPEUTIC ASPECTS

      Medicamentos de actualidad
    24. LANGLOIS A; PASCAUD X; JUNIEN JL; DAHL SG; RIVIERE PJM
      RESPONSE HETEROGENEITY OF 5-HT3 RECEPTOR ANTAGONISTS IN A RAT VISCERAL HYPERSENSITIVITY MODEL

      European journal of pharmacology
    25. DYR W; KOSTOWSKI W
      EVIDENCE THAT THE AMYGDALA IS INVOLVED IN THE INHIBITORY EFFECTS OF 5-HT3 RECEPTOR ANTAGONISTS ON ALCOHOL-DRINKING IN RATS

      Alcohol
    26. JANKOWSKA E; KOSTOWSKI W
      THE EFFECT OF TROPISETRON INJECTED INTO THE NUCLEUS-ACCUMBENS-SEPTI ON ETHANOL-CONSUMPTION IN RATS

      Alcohol
    27. TERRYNATHAN VR; GIETZEN DW; ROGERS QR
      SEROTONIN(3) ANTAGONISTS BLOCK AVERSION TO SACCHARIN IN AN AMINO ACID-IMBALANCED DIET

      American journal of physiology. Regulatory, integrative and comparative physiology
    28. GRANDE L; LACIMA G; PEREZ A; ZAYAS JM
      LACK OF EFFECT OF A 5-HT3 ANTAGONIST, PANCOPRIDE, ON LOWER ESOPHAGEALSPHINCTER PRESSURE IN VOLUNTEERS

      British journal of clinical pharmacology
    29. MOSER PC
      THE EFFECT OF 5-HT3 RECEPTOR ANTAGONISTS ON THE WRITHING RESPONSE IN MICE

      General pharmacology
    30. BENDELE A; MEANS J; SHOUFLER J; SCHMALZ C; HANASONO G; SYMANOWSKI J; ADAMS E
      CHRONIC TOXICITY OF ZATOSETRON, A 5-HT3 RECEPTOR ANTAGONIST, IN RHESUS-MONKEYS

      Drug and chemical toxicology
    31. CAMPBELL AD; MCBRIDE WJ
      SEROTONIN-3 RECEPTOR AND ETHANOL-STIMULATED DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS

      Pharmacology, biochemistry and behavior
    32. WEST WB; VANGROLL BJ; APPEL JB
      STIMULUS EFFECTS OF D-AMPHETAMINE-II - DA, NE, AND 5-HT MECHANISMS

      Pharmacology, biochemistry and behavior
    33. FALKSON CI; FALKSON HC
      ANTIEMETIC EFFICACY OF TROPISETRON IN PATIENTS FAILING PREVIOUS ANTIEMETIC THERAPY

      Oncology
    34. VANWYK M; SOMMERS DK; SNYMAN JR; MONCRIEFF J
      THE EFFECT OF METOCLOPRAMIDE, ONDANSETRON, AND GRANISETRON ON LIQUID GASTRIC-EMPTYING IN NORMAL SUBJECTS

      Current therapeutic research
    35. BANNER SE; SANGER GJ
      DIFFERENCES BETWEEN 5-HT3 RECEPTOR ANTAGONISTS IN MODULATION OF VISCERAL HYPERSENSITIVITY

      British Journal of Pharmacology
    36. TOMKINS DM; LE AD; SELLERS EM
      EFFECT OF THE 5-HT3 ANTAGONIST ONDANSETRON ON VOLUNTARY ETHANOL INTAKE IN RATS AND MICE MAINTAINED ON A LIMITED ACCESS PROCEDURE

      Psychopharmacology
    37. ANDERSON H; THATCHER N; HOWELL A; LOGAN K; SAGE T; DEBRUIJN KM
      TROPISETRON COMPARED WITH A METOCLOPRAMIDE-BASED REGIMEN IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

      European journal of cancer
    38. SUAREZ A; STETTLER ER; REY E; PONS G; SIMONETTACHATEAUNEUF C; DEBRUIJN KM; OLIVE G; LEMERLE J
      SAFETY, TOLERABILITY, EFFICACY AND PLASMA-CONCENTRATIONS OF TROPISETRON AFTER ADMINISTRATION AT 5 DOSE LEVELS TO CHILDREN RECEIVING CANCER-CHEMOTHERAPY

      European journal of cancer
    39. SUAREZ A; STETTLER ER; REY E; PONS G; SIMONETTACHATEAUNEUF C; DEBRUIJN KM; OLIVE G; LEMERLE J
      SAFETY, TOLERABILITY, EFFICACY AND PLASMA-CONCENTRATIONS OF TROPISETRON AFTER ADMINISTRATION AT 5 DOSE LEVELS TO CHILDREN RECEIVING CANCER-CHEMOTHERAPY

      European journal of cancer
    40. HAVSTEEN H; ANDERSEN LJ; KJAER M; DALMARK M
      ON-DEMAND ANTIEMETIC TREATMENT WITH THE SEROTONINE ANTAGONIST TROPISETRON IN CISPLATIN-TREATED CANCER-PATIENTS

      Anti-cancer drugs
    41. VANBELLE SJP; STAMATAKIS L; BLEIBERG H; COCQUYT VFJ; MICHEL J; DEBRUIJN KM
      DOSE-FINDING STUDY OF TROPISETRON IN CISPLATIN-INDUCED NAUSEA AND VOMITING

      Annals of oncology
    42. KLEIN RL; SANNA E; MCQUILKIN SJ; WHITING PJ; HARRIS RA
      EFFECTS OF 5-HT3 RECEPTOR ANTAGONISTS ON BINDING AND FUNCTION OF MOUSE AND HUMAN GABA(A) RECEPTORS

      European journal of pharmacology. Molecular pharmacology section
    43. MORTEAU O; JULIA V; EECKHOUT C; BUENO L
      INFLUENCE OF 5-HT3 RECEPTOR ANTAGONISTS IN VISCEROMOTOR AND NOCICEPTIVE RESPONSES TO RECTAL DISTENSION BEFORE AND DURING EXPERIMENTAL COLITIS IN RATS

      Fundamental and clinical pharmacology
    44. ROSSO P; DIMONTEZEMOLO LC; VIVENZA C; NASI C; TONELLO M; VALLE P; MADON E
      EFFICACY OF TROPISETRON (NAVOBAN(R)) IN CONTROLLING EMESIS INDUCED INCHILDREN BY ANTICANCER THERAPY

      Tumori
    45. ZERBIB F; DESVARANNES SB; ORIOLA RC; MCDONALD J; ISAL JP; GALMICHE JP
      ALOSETRON DOES NOT AFFECT THE VISCERAL PERCEPTION OF GASTRIC DISTENSION IN HEALTHY-SUBJECTS

      Alimentary pharmacology & therapeutics
    46. READ NW; GWEE KA
      THE IMPORTANCE OF 5-HYDROXYTRYPTAMINE RECEPTORS IN THE GUT

      Pharmacology & therapeutics
    47. CORRIGALL WA; COEN KM
      NICOTINE SELF-ADMINISTRATION AND LOCOMOTOR-ACTIVITY ARE NOT MODIFIED BY THE 5-HT3 ANTAGONISTS ICS-205-930 AND MDL-72222

      Pharmacology, biochemistry and behavior
    48. SCHWARTZ SA; GOLDBERG MJ; GIDDA JS; CERIMELE BJ
      EFFECT OF ZATOSETRON ON IPECAC-INDUCED EMESIS IN DOGS AND HEALTHY-MEN

      Journal of clinical pharmacology
    49. KOOYMAN AR; ZWART R; VANDERHEIJDEN PML; VANHOOFT JA; VIJVERBERG HPM
      INTERACTION BETWEEN ENANTIOMERS OF MIANSERIN AND ORG3770 AT 5-HT3, RECEPTORS IN CULTURED MOUSE NEUROBLASTOMA-CELLS

      Neuropharmacology
    50. ROYCHOWDHURY S; HAAS H; ANDERSON EG
      5-HT1A AND 5-HT4, RECEPTOR COLOCALIZATION ON HIPPOCAMPAL PYRAMIDAL CELLS

      Neuropharmacology
    51. SANGER GJ; WARDLE KA
      CONSTIPATION EVOKED BY 5-HT3-RECEPTOR ANTAGONISM - EVIDENCE FOR HETEROGENEOUS EFFICACY AMONG DIFFERENT ANTAGONISTS IN GUINEA-PIGS

      Journal of Pharmacy and Pharmacology
    52. SORBE BG; HOGBERG T; GLIMELIUS B; SCHMIDT M; WERNSTEDT L; HANSEN O; SORENSEN BT; RAISANEN I; VANOOSTEROM AT; DEBRUIJN KM
      A RANDOMIZED, MULTICENTER STUDY COMPARING THE EFFICACY AND TOLERABILITY OF TROPISETRON, A NEW 5-HT3 RECEPTOR ANTAGONIST, WITH A METOCLOPRAMIDE-CONTAINING ANTIEMETIC COCKTAIL IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS

      Cancer
    53. HANSEN MB
      ICS-205-930 REDUCES 5-METHOXYTRYPTAMINE-INDUCED SHORT-CIRCUIT CURRENTIN STRIPPED PIG JEJUNUM

      Canadian journal of physiology and pharmacology
    54. DELORENZI FG; BRIDAL TR; SPINELLI W
      BLOCK OF THE DELAYED RECTIFIER CURRENT (I-K) BY THE 5-HT3 ANTAGONISTSONDANSETRON AND GRANISETRON IN FELINE VENTRICULAR MYOCYTES

      British Journal of Pharmacology
    55. WARDLE KA; ELLIS ES; BAXTER GS; KENNETT GA; GASTER LM; SANGER GJ
      THE EFFECTS OF SB-204070, A HIGHLY POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST, ON GUINEA-PIG DISTAL COLON

      British Journal of Pharmacology
    56. LEMARQUAND D; PIHL RO; BENKELFAT C
      SEROTONIN AND ALCOHOL INTAKE, ABUSE, AND DEPENDENCE - FINDINGS OF ANIMAL STUDIES

      Biological psychiatry
    57. HAGA K; ASANO K; INABA K; MORIMOTO Y; SETOGUCHI M
      EFFECT OF Y-25130, A SELECTIVE 5-HYDROXYTRYPTAMINE(3) RECEPTOR ANTAGONIST, ON GASTRIC-EMPTYING IN MICE

      Archives internationales de pharmacodynamie et de therapie
    58. WASHBURN BS; JIANG JC; CUMMINGS SL; DIXON K; GIETZEN DW
      ANORECTIC RESPONSES TO DIETARY AMINO-ACID IMBALANCE - EFFECTS OF VAGOTOMY AND TROPISETRON

      The American journal of physiology
    59. HEYMAN JS; YOUNG ML; BAGSHAW RJ; LEVY WJ; GEER RT; AUKBURG SJ; JOSLYN AF; CONAHAN TJ
      CARDIOVASCULAR STABILITY WITH RAPID INTRAVENOUS-INFUSION OF ONDANSETRON

      Canadian journal of anaesthesia
    60. KOSTOWSKI W; DYR W; KRZASCIK P
      THE ABILITIES OF 5-HT(3)RECEPTOR ANTAGONIST ICS 205-930 TO INHIBIT ALCOHOL PREFERENCE AND WITHDRAWAL SEIZURES IN RATS

      Alcohol
    61. HODGE CW; SAMSON HH; LEWIS RS; ERICKSON HL
      SPECIFIC DECREASES IN ETHANOL- BUT NOT WATER-REINFORCED RESPONDING PRODUCED BY THE 5-HT3 ANTAGONIST ICS 205-930

      Alcohol
    62. BELLINGER LL; GIETZEN DW; WILLIAMS FE
      LIVER DENERVATION, 5-HT3 RECEPTOR ANTAGONIST, AND INTAKE OF IMBALANCED AMINO-ACID DIET

      Brain research bulletin
    63. COSTALL B; NAYLOR RJ
      THE PHARMACOLOGY OF THE 5-HT4 RECEPTOR

      International clinical psychopharmacology
    64. INOUE A; TOMINAGA Y; NISHIO H; SEGAWA T; NAKATA Y
      EFFECTS OF DETERGENTS ON BINDING OF 5-HYDROXYTRYPTAMINE(3) RECEPTOR ANTAGONIST [H-3] GR65630 TO RAT CORTICAL MEMBRANES

      Neurochemistry international
    65. OHMORI T; KUWAHARA A; OZAKI T; YANAIHARA N; TAKEDA Y; TAKEDA R
      SUBSTANCE-P-EVOKED CIRCULAR MUSCLE CONTRACTIONS HAVE A CLOSE CONNECTION WITH SEROTONERGIC NEURONS IN GUINEA-PIG ILEUM

      Regulatory peptides
    66. HOF RP; HOF A; NOVOSEL D; ZIERHUT W
      ANTIARRHYTHMIC AND HEMODYNAMIC-EFFECTS OF TROPISETRON IN ANESTHETIZEDRABBITS

      Journal of cardiovascular pharmacology
    67. BUFTON KE; STEWARD LJ; BARBER PC; BARNES NM
      DISTRIBUTION AND CHARACTERIZATION OF THE [H-3] GRANISETRON-LABELED 5-HT3 RECEPTOR IN THE HUMAN FOREBRAIN

      Neuropharmacology
    68. LEE CR; PLOSKER GL; MCTAVISH D
      TROPISETRON - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL AS AN ANTIEMETIC

      Drugs
    69. RIZZI CA; PRUDENTINO A; GIRALDO E
      EFFECTS ON GENERAL BEHAVIOR AND NEUROTRANSMITTER FUNCTIONS OF A NEW 5-HYDROXYTRYPTAMINE(3) RECEPTOR ANTAGONIST WITH POTENTIAL THERAPEUTIC RELEVANCE IN CENTRAL-NERVOUS-SYSTEM DISTURBANCES

      Arzneimittel-Forschung
    70. YOSHIDA N; OMOYA H; KATO S; ITO T
      PHARMACOLOGICAL EFFECTS OF THE NEW GASTROPROKINETIC AGENT MOSAPRIDE CITRATE AND ITS METABOLITES IN EXPERIMENTAL-ANIMALS

      Arzneimittel-Forschung


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 16:29:08